Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

Clinical trial NCT02559960 · SUSPENDED

Trial details

NCT number: NCT02559960
Sponsor: Zhong Wang
Status: SUSPENDED
Study type: OBSERVATIONAL

Adverse Drug Event Adverse Drug Reaction Chinese Medicine Anaphylactic Reaction

Start date: 2015-09-01
Primary completion: 2021-08-01
Enrollment: 20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.